Influence of the autonomic nervous system on the Q-T interval in man

Kevin F. Browne, Douglas P. Zipes, James J. Heger, Eric N. Prystowsky

Research output: Contribution to journalArticle

217 Citations (Scopus)

Abstract

Drugs that affect the autonomic nervous system can influence the Q-T interval directly or by changing the heart rate. Bazett's formula to correct for rate may be misleading after certain drug interventions. This hypothesis was tested in 20 patients receiving both propranolol (0.15 mg/kg intravenously) and atropine (0.03 mg/kg intravenously). Six patients received propranolol first, 7 patients received atropine first, and 7 patients received atropine plus propranolol simultaneously. During control and after drug intervention, the Q-T interval was measured directly in sinus rhythm and during a fixed atrial paced rate, and was calculated using Bazett's formula. The ventricular effective refractory period was also determined in 6 patients after administration of atropine plus propranolol. The sinus cycle length (836 ± 156 to 648 ± 84 ms, mean ± standard deviation), measured Q-T interval (367 ± 26 to 329 ± 26 ms), and atrially paced Q-T interval (330 ± 28 to 315 ±27 ms) shortened after atropine plus propranolol (p <0.001), but the corrected Q-T interval with use of Bazett's formula did not change (402 ± 33 to 412 ± 24 ms). The ventricular effective refractory period also shortened from 241 to 20 to 218 ± 21 ms after atropine plus propranolol (p <0.02). The sinus cycle length increased after propranolol (750 ± 97 to 907 ± 108 ms, p <0.001), but no change occurred in the measured Q-T interval or atrial paced Q-T interval although the corrected Q-T interval using Bazett's formula was greatly shortened (428 ± 15 to 391 ±22 ms, p <0.001). The sinus cycle length, measured Q-T interval, and atrially paced Q-T interval decreased after atropine (p <0.01), but the corrected Q-T interval lengthened (375 ± 29 to 418 ± 28 ms, p <0.01). In summary, atropine and atropine plus propranolol shorten the Q-T interval independent of rate, demonstrating a direct vagal effect on the Q-T interval. Bazett's formula inaccurately predicts the Q-T interval after administration of atropine, propranolol, and atropine plus propranolol.

Original languageEnglish
Pages (from-to)1099-1103
Number of pages5
JournalThe American Journal of Cardiology
Volume50
Issue number5
DOIs
StatePublished - 1982

Fingerprint

Autonomic Nervous System
Atropine
Propranolol
Drug and Narcotic Control
Pharmaceutical Preparations
Heart Rate

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Influence of the autonomic nervous system on the Q-T interval in man. / Browne, Kevin F.; Zipes, Douglas P.; Heger, James J.; Prystowsky, Eric N.

In: The American Journal of Cardiology, Vol. 50, No. 5, 1982, p. 1099-1103.

Research output: Contribution to journalArticle

Browne, Kevin F. ; Zipes, Douglas P. ; Heger, James J. ; Prystowsky, Eric N. / Influence of the autonomic nervous system on the Q-T interval in man. In: The American Journal of Cardiology. 1982 ; Vol. 50, No. 5. pp. 1099-1103.
@article{bf9823ed7c4047a7a025ebd5c3e5ee20,
title = "Influence of the autonomic nervous system on the Q-T interval in man",
abstract = "Drugs that affect the autonomic nervous system can influence the Q-T interval directly or by changing the heart rate. Bazett's formula to correct for rate may be misleading after certain drug interventions. This hypothesis was tested in 20 patients receiving both propranolol (0.15 mg/kg intravenously) and atropine (0.03 mg/kg intravenously). Six patients received propranolol first, 7 patients received atropine first, and 7 patients received atropine plus propranolol simultaneously. During control and after drug intervention, the Q-T interval was measured directly in sinus rhythm and during a fixed atrial paced rate, and was calculated using Bazett's formula. The ventricular effective refractory period was also determined in 6 patients after administration of atropine plus propranolol. The sinus cycle length (836 ± 156 to 648 ± 84 ms, mean ± standard deviation), measured Q-T interval (367 ± 26 to 329 ± 26 ms), and atrially paced Q-T interval (330 ± 28 to 315 ±27 ms) shortened after atropine plus propranolol (p <0.001), but the corrected Q-T interval with use of Bazett's formula did not change (402 ± 33 to 412 ± 24 ms). The ventricular effective refractory period also shortened from 241 to 20 to 218 ± 21 ms after atropine plus propranolol (p <0.02). The sinus cycle length increased after propranolol (750 ± 97 to 907 ± 108 ms, p <0.001), but no change occurred in the measured Q-T interval or atrial paced Q-T interval although the corrected Q-T interval using Bazett's formula was greatly shortened (428 ± 15 to 391 ±22 ms, p <0.001). The sinus cycle length, measured Q-T interval, and atrially paced Q-T interval decreased after atropine (p <0.01), but the corrected Q-T interval lengthened (375 ± 29 to 418 ± 28 ms, p <0.01). In summary, atropine and atropine plus propranolol shorten the Q-T interval independent of rate, demonstrating a direct vagal effect on the Q-T interval. Bazett's formula inaccurately predicts the Q-T interval after administration of atropine, propranolol, and atropine plus propranolol.",
author = "Browne, {Kevin F.} and Zipes, {Douglas P.} and Heger, {James J.} and Prystowsky, {Eric N.}",
year = "1982",
doi = "10.1016/0002-9149(82)90425-8",
language = "English",
volume = "50",
pages = "1099--1103",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Influence of the autonomic nervous system on the Q-T interval in man

AU - Browne, Kevin F.

AU - Zipes, Douglas P.

AU - Heger, James J.

AU - Prystowsky, Eric N.

PY - 1982

Y1 - 1982

N2 - Drugs that affect the autonomic nervous system can influence the Q-T interval directly or by changing the heart rate. Bazett's formula to correct for rate may be misleading after certain drug interventions. This hypothesis was tested in 20 patients receiving both propranolol (0.15 mg/kg intravenously) and atropine (0.03 mg/kg intravenously). Six patients received propranolol first, 7 patients received atropine first, and 7 patients received atropine plus propranolol simultaneously. During control and after drug intervention, the Q-T interval was measured directly in sinus rhythm and during a fixed atrial paced rate, and was calculated using Bazett's formula. The ventricular effective refractory period was also determined in 6 patients after administration of atropine plus propranolol. The sinus cycle length (836 ± 156 to 648 ± 84 ms, mean ± standard deviation), measured Q-T interval (367 ± 26 to 329 ± 26 ms), and atrially paced Q-T interval (330 ± 28 to 315 ±27 ms) shortened after atropine plus propranolol (p <0.001), but the corrected Q-T interval with use of Bazett's formula did not change (402 ± 33 to 412 ± 24 ms). The ventricular effective refractory period also shortened from 241 to 20 to 218 ± 21 ms after atropine plus propranolol (p <0.02). The sinus cycle length increased after propranolol (750 ± 97 to 907 ± 108 ms, p <0.001), but no change occurred in the measured Q-T interval or atrial paced Q-T interval although the corrected Q-T interval using Bazett's formula was greatly shortened (428 ± 15 to 391 ±22 ms, p <0.001). The sinus cycle length, measured Q-T interval, and atrially paced Q-T interval decreased after atropine (p <0.01), but the corrected Q-T interval lengthened (375 ± 29 to 418 ± 28 ms, p <0.01). In summary, atropine and atropine plus propranolol shorten the Q-T interval independent of rate, demonstrating a direct vagal effect on the Q-T interval. Bazett's formula inaccurately predicts the Q-T interval after administration of atropine, propranolol, and atropine plus propranolol.

AB - Drugs that affect the autonomic nervous system can influence the Q-T interval directly or by changing the heart rate. Bazett's formula to correct for rate may be misleading after certain drug interventions. This hypothesis was tested in 20 patients receiving both propranolol (0.15 mg/kg intravenously) and atropine (0.03 mg/kg intravenously). Six patients received propranolol first, 7 patients received atropine first, and 7 patients received atropine plus propranolol simultaneously. During control and after drug intervention, the Q-T interval was measured directly in sinus rhythm and during a fixed atrial paced rate, and was calculated using Bazett's formula. The ventricular effective refractory period was also determined in 6 patients after administration of atropine plus propranolol. The sinus cycle length (836 ± 156 to 648 ± 84 ms, mean ± standard deviation), measured Q-T interval (367 ± 26 to 329 ± 26 ms), and atrially paced Q-T interval (330 ± 28 to 315 ±27 ms) shortened after atropine plus propranolol (p <0.001), but the corrected Q-T interval with use of Bazett's formula did not change (402 ± 33 to 412 ± 24 ms). The ventricular effective refractory period also shortened from 241 to 20 to 218 ± 21 ms after atropine plus propranolol (p <0.02). The sinus cycle length increased after propranolol (750 ± 97 to 907 ± 108 ms, p <0.001), but no change occurred in the measured Q-T interval or atrial paced Q-T interval although the corrected Q-T interval using Bazett's formula was greatly shortened (428 ± 15 to 391 ±22 ms, p <0.001). The sinus cycle length, measured Q-T interval, and atrially paced Q-T interval decreased after atropine (p <0.01), but the corrected Q-T interval lengthened (375 ± 29 to 418 ± 28 ms, p <0.01). In summary, atropine and atropine plus propranolol shorten the Q-T interval independent of rate, demonstrating a direct vagal effect on the Q-T interval. Bazett's formula inaccurately predicts the Q-T interval after administration of atropine, propranolol, and atropine plus propranolol.

UR - http://www.scopus.com/inward/record.url?scp=0020427941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020427941&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(82)90425-8

DO - 10.1016/0002-9149(82)90425-8

M3 - Article

C2 - 7137037

AN - SCOPUS:0020427941

VL - 50

SP - 1099

EP - 1103

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -